000 01248 a2200337 4500
005 20250512205554.0
264 0 _c19830729
008 198307s 0 0 eng d
022 _a0003-4819
024 7 _a10.7326/0003-4819-99-1-106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarey, M P
245 0 0 _aDelta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
_h[electronic resource]
260 _bAnnals of internal medicine
_cJul 1983
300 _a106-14 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAntiemetics
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aClinical Trials as Topic
_xmethods
650 0 4 _aDronabinol
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aDrug Tolerance
650 0 4 _aHumans
650 0 4 _aNausea
_xchemically induced
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aResearch Design
700 1 _aBurish, T G
700 1 _aBrenner, D E
773 0 _tAnnals of internal medicine
_gvol. 99
_gno. 1
_gp. 106-14
856 4 0 _uhttps://doi.org/10.7326/0003-4819-99-1-106
_zAvailable from publisher's website
999 _c6305174
_d6305174